SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-08-069753
Filing Date
2008-11-10
Accepted
2008-11-10 16:34:12
Documents
5
Period of Report
2008-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a08-27948_110q.htm 10-Q 684163
2 EX-31.1 a08-27948_1ex31d1.htm EX-31.1 12463
3 EX-31.2 a08-27948_1ex31d2.htm EX-31.2 12316
4 EX-32.1 a08-27948_1ex32d1.htm EX-32.1 6919
5 EX-32.2 a08-27948_1ex32d2.htm EX-32.2 6899
  Complete submission text file 0001104659-08-069753.txt   724290
Mailing Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069
Business Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069 8474780500
BIOSANTE PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

IRS No.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31812 | Film No.: 081176159
SIC: 2836 Biological Products, (No Diagnostic Substances)